PCV13 vaccination impact: A multicenter study of pneumonia in 10 pediatric hospitals in Argentina.

Ángela GentileJulia BakirVerónica FirpoEnrique V CasanuevaGabriela EnsinckSantiago Lopez PapucciMaría F LuciónHector AbateAldo CancellaraFabiana MolinaAndrea Gajo GaneAlfredo M CarusoAlejandro Santillán IturresSofía Fossatinull null

Published in: PloS one (2018)

After PCV13 introduction, significant reduction in CP and PP discharge rates was observed in hospitalized children <5 years. In patients ≥5 years, PP discharge rate also decreased significantly.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
young adults
prognostic factors
respiratory failure
community acquired pneumonia